Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation in a lung transplant recipient
Preprint
Abstract
Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation (ECMO) has not been previously studied. In this work we report on the ceftolozane and tazobactam plasmatic levels in a lung transplant recipient during ECMO, treated with ceftolozane-tazobactam (2g/1g, intravenously every 8 h, 1 h infusion) for a Pseudomonas aeruginosa pulmonary infection. Ceftolozane Cmax and Cmin, monitored during 96 hrs, remained above 60 and 20 μg/mL, respectively, with optimal drug exposure (100% % T MIC ). Tazobactam levels were above 1.9 μg/mL.Keywords
All Related Versions
- Published version: Antimicrobial Agents and Chemotherapy, 63 (3).
This publication has 12 references indexed in Scilit:
- Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infectionsInfection, 2018
- Ceftolozane/tazobactam: place in therapyExpert Review of Anti-infective Therapy, 2018
- Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of ResistanceClinical Infectious Diseases, 2017
- Extracorporeal membrane oxygenation in the pre and post lung transplant periodAnnals of Translational Medicine, 2017
- Successful Use of Ceftolozane‐Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug‐Resistant Pseudomonas aeruginosaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β‐Lactamase Inhibitor CombinationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumoniaThe Journal of Clinical Pharmacology, 2015
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative BacilliDrugs, 2013
- Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection ModelAntimicrobial Agents and Chemotherapy, 2013
- Pharmacokinetics and Safety of Intravenous Ceftolozane-Tazobactam in Healthy Adult Subjects following Single and Multiple Ascending DosesAntimicrobial Agents and Chemotherapy, 2012